CERTAINTY-Virtual Twin

CERTAINTY (A Cellular Immunotherapy Virtual Twin for Personalised Cancer Treatment) is a four-year research project funded by the European Union under Grant Agreement number 101136379. It brings together 17 partners from across Europe, coordinated by Fraunhofer (Germany), with a shared mission to personalise cancer care.

The project is focused on developing a virtual twin for patients undergoing CAR T cell therapy, a pioneering form of cancer treatment. By creating a computational model that mirrors individual patients, CERTAINTY aims to support doctors and patients with insights that may guide treatment decisions and improve outcomes.

Our goal is to contribute to a more informed, data-driven approach to cancer therapy, enhancing the effectiveness and safety of personalised treatments through cutting-edge digital tools.